Drug-resistant bacteria are "a hidden epidemic"

01/22/2013 | Philadelphia Inquirer, The

Bacteria are quickly becoming resistant to known antibiotics, and few new drugs are being developed to fill the void, experts say. Antibiotics are not as profitable for drugmakers as drugs to treat chronic diseases, so the federal government should develop a system to reward discovery and development of new antibiotics, says infectious disease specialist Jeffrey Jacobson.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC